ПОЛНОРАЗМЕРНЫЙ ПЕПТИДНЫЙ АНАЛИЗ АНТИГЕННОГО ПРОФИЛЯ ПОВЕРХНОСТНЫХ БЕЛКОВ СИБИРСКИХ ИЗОЛЯТОВ ВИРУСА ГЕПАТИТА C
https://doi.org/10.15789/1563-0625-2010-1-2-115-124
Аннотация
Об авторах
А. А. ГражданцеваРоссия
Г. Ф. Сиволобова
Россия
M. Major
Россия
Е. В. Чуб
Россия
А. Н. Швалов
Россия
П. В. Юдин
Россия
С. В. Нетесов
Россия
В. Б. Локтев
Россия
Г. В. Кочнева
Россия
Список литературы
1. Шустов А.В., Кочнева Г.В., Сиволобова Г.Ф., Гражданцева А.А., Гаврилова И.В., Нестеров А.Е., Стрельцова М.А., Пальцев А.И., Локтев А.В., Максютов А.З., Акинфеева Л.А., Торшин В.П., West T.E., Ryder R.W., Онищенко Г.Г. Частота встречаемости маркеров гепатита С и факторы риска у персонала больниц Новосибирской области // Журн. микробиол. эпидемиол. и иммунобиологии (ЖМЭИ). -2002. -T. 2. - C. 26-32.
2. Bowen D.G., Walker C.M. Adaptive immune responses in acute and chronic hepatitis C virus infection // Nature. -2005. -Vol. 436. -P. 946-952.
3. Bukh J., Miller R.H., Purcell R.H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes // Semin Liver Dis. -1995. -Vol. 15. -P. 41-63.
4. Carlos M.P., Yamamura Y., Vu Q., Conzen K., Anderson D.E., Torres J.V. Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes 1a or 1b // Clin. Immunol. -2004. -Vol. 111. -P. 22-27.
5. Farci P., Shimoda A., Wong D., Cabezon T., De Gioannis D., Strazzera A., Shimizu Y., Shapiro M., Alter H., Purcell R. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein // Proc. Natl. Acad. Sci. USA. -1996. -Vol. 93. -P. 15394-15399.
6. Gotto J., Dusheiko G.M. Hepatitis C and treatment with pegylated interferon and ribavirin // Int. J. Biochem. Cell Biol. -2004. -Vol. 36, N 10. -P. 1874-1877.
7. Ishida C., Matsumoto K., Fukada K., Matsushita K., Shiraki H., Maeda Y. Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens // J. Clin. Microbiol. -1993. -Vol. 31. -P. 936-940.
8. Keck Z-Y., Sung V.M.H., Perkins S., Rowe J., Paul S., Liang T.J., Lai M.M.C., Foung S.K.H. Human monoclonal antibody to hepatitis C Virus E1 glycoprotein that blocks virus attachment and viral infectivity//J. Virol. -2004. -Vol. 78, N 13. -P. 7257-7263.
9. Lecnmann M., Ihlenfeldt H.G., Braunschweiger I., Gierls G., Jung G., Matz B., Kaiser R., Sauberbruch T., Spengler U. T and B Cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia // Hepatology. -1996. -Vol. 24, N 4. -P. 790-795.
10. Martinez-Donato G., Duenas-Carrera S., Alvarez-Lajonchere L., Morales J., Acosta-Rivero N., Martínez E., Viña A., Guerra I., Prez A., Musacchio A., García J., Reyes O., Garay H.E., González L.J., Alvarez J.C., Soria Y. Antigenicity and immunogenecity of the hepatitis C virus envelope E2 protein // Biotecnologia Aplicada. -2006. -Vol. 23, N 1. -P. 60-63.
11. Meunier J.C., Russell R.S., Goossens V., Priem S., Walter H., Depla E., Union A., Faulk K.N., Bukh J., Emerson S.U., Purcell R.H. Isolation and characterization of broadly neutralizing human monoclonal antibodies to the E1 glycoprotein of hepatitis C virus // J. Virol. -2008. -Vol. 82, N 2. -P. 966-973.
12. Olenina L.V., Nikolaeva L.I., Sobolev B.N., Blokhina N.P., Archakov A.I., Kolesanova E.F. Mapping and characterization of B cell linear epitopes in the conservative regions of hepatitis C virus envelope glycoproteins // J. Viral. Hepat. -2002. -Vol. 9. -P. 174-182.
13. Perotti M., Mancini N., Diotti R.A., Tarr A.W., Ball J.K., Owsianka A., Adair R., Patel A.H., Clementi M., Burioni R. Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein // J. Virol. -2008. -Vol. 82, N 2. - P. 1047-1052.
14. Petit M.-A., Jolivet-Reynaud C., Peronnet E., Michal Y., Tre'po C. Mapping of a conformational epitope shared between E1 and E2 on the serum-derived human hepatitis C virus envelope // J. Biol. Chem. -2003. -Vol. 278, N 45. -P. 44385-44392.
15. Petrik J., Alexander G.J.M., Pearson G., Allain J.P. Reactivity of synthetic peptides representing selected sections of hepatitis C virus Core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma//J. Med. Virol. -1997. -Vol. 51. -P. 67-79.
16. Sallberg M., Ruden U., Wahren B., Magnius L.O. Antigenic regions within the hepatitis C virus envelope 1 and structural proteins: identification of an IgG3-restricted recognition site within the envelope 1 protein // Clin. Exp. Imunol. -1993. -Vol. 91. -P. 489-494.
17. Seeff L.B. Natural history of chronic hepatitis C // Hepatology. -2002. -Vol. 36, N 5. - P. 35-46.
18. Shimizu Y.K., Igarashi H., Kiyohara T. A hyperimmune constructs against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures // Virol. -1996. -Vol. 223. -P. 409-412.
19. Simmonds P., Rose K.A., Graham S., Chan S.W., McOmish F., Dow B.C., Follet E.A., Yap P.L., Marsden H. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3 // J. Clin. Microbiol. -1993. -Vol. 31. -P. 1493-1503.
20. Simmonds P. The origin and evolution of hepatitis viruses in humans // J. Gen. Virol. -2001. -Vol. 82. -P. 693-712.
21. Tarr A.W., Owsianka A.M., Timms J.M., Patrick McClure C., Brown R.J.P., Hickling T.P., Pietschmann T., Bartenschlager R., Patel A.H., Ball J.K. Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33 // Hepatology. -2006. -Vol. 43, N 3. -P. 592-601.
22. Tarr A.W., Owsianka A.M., Szwejk A., Ball J.K., Patel A.H. Cloning, expression and functional analysis of patient-derived hepatitis C virus glycoproteins // Methods Mol. Biol. -2007. -Vol. 379. -P. 177-197.
23. Tarr A.W., Owsianka A.M., Jayaraj D., Brown R.J.P., Hickling T.P., Irving W.L., Patel A.H., Ball J.K. Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33 // J. Gen. Virol. -2007. -Vol. 88. -Р. 2991-3001.
24. Zhang Z.-X., Sonnerborg A., Sallberg M. Antigenic structure of the hepatitis C virus envelope 2 protein // Clin. Exp. Immunol. -1994. -Vol. 98. -P. 382-387.
25. Zang P., Wu C.G., Mihalik K., Virata-Theimer M.L., Yu M.W., Alter H.J., Feinstone S.M. Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma // Proc. Natl. Acad. Sci. USA. -2007. -Vol. 104, N 20. -P. 8449-8454.
26. Zhang P., Zhong L., Struble E. B., Watanabe H., Kachko A., Mihalik K., Virata-Theimer M.L., Alter H.J., Feinstone S., Major M. Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity // Proc. Natl. Acad. Sci. USA. -2009. -Vol. 106, N 18. -P. 537-541.
Рецензия
Для цитирования:
Гражданцева А.А., Сиволобова Г.Ф., Major M., Чуб Е.В., Швалов А.Н., Юдин П.В., Нетесов С.В., Локтев В.Б., Кочнева Г.В. ПОЛНОРАЗМЕРНЫЙ ПЕПТИДНЫЙ АНАЛИЗ АНТИГЕННОГО ПРОФИЛЯ ПОВЕРХНОСТНЫХ БЕЛКОВ СИБИРСКИХ ИЗОЛЯТОВ ВИРУСА ГЕПАТИТА C. Медицинская иммунология. 2010;12(1-2):115-124. https://doi.org/10.15789/1563-0625-2010-1-2-115-124
For citation:
Grazhdantseva A.A., Sivolobova G.F., Major M., Chub E.V., Shvalov A.N., Yudin P.V., Netesov S.V., Loktev V.B., Kochneva G.V. FULL-LENGTH PEPTIDE ASSAY OF ANTIGENIC PROFILE OF ENVELOPE PROTEINS FROM SIBERIAN ISOLATES OF HEPATITIS C VIRUS. Medical Immunology (Russia). 2010;12(1-2):115-124. (In Russ.) https://doi.org/10.15789/1563-0625-2010-1-2-115-124